# Nodality

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nodality

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: www.nodalityinc.com
- Total disclosed funding: $72M
- Latest round: Series C (Mar 22, 2010)
- Investors on record: 6

## About

Established in 2003 and based in the US, Nodality is a biotechnology company focused on developing highly predictive tests to enable biologically-informed clinical treatment decisions in patients with cancer and autoimmune disease.

## Funding rounds

- Series C, Mar 22, 2010, $16M — Kleiner Perkins, TPG Biotech, Laboratory Corporation of America Holdings, Pfizer Venture Investments, Maverick Capital
- Series B, Oct 27, 2009, $3.5M — Kleiner Perkins, TPG, Maverick Capital
- Series B, Mar 16, 2009, $20M — Kleiner Perkins, TPG Biotech, Pfizer Venture Investments, Maverick Capital
- Series B, Mar 19, 2008, $22M — Kleiner Perkins, Maverick Capital
- Series A, Feb 1, 2007, $11M — Kleiner Perkins, TPG Biotech

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series A, Series B, Series C
- TPG Biotech (https://capitalatlas.ai/funds/tpg-biotech) — Series A, Series B, Series C
- Maverick Capital (https://capitalatlas.ai/funds/maverick-capital) — Series B, Series C
- Pfizer Venture Investments (https://capitalatlas.ai/funds/pfizer-venture-investments) — Series B, Series C
- TPG (https://capitalatlas.ai/funds/tpg) — Series B
- Laboratory Corporation of America Holdings — Series C